These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29188418)

  • 1. Imaging of Nanoparticle Distribution to Assess Treatments That Alter Delivery.
    Blocker SJ; Shields AF
    Mol Imaging Biol; 2018 Jun; 20(3):340-351. PubMed ID: 29188418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle delivery in vivo: A fresh look from intravital imaging.
    Lin Q; Fathi P; Chen X
    EBioMedicine; 2020 Sep; 59():102958. PubMed ID: 32853986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia.
    Wang C; Hsu CH; Li Z; Hwang LP; Lin YC; Chou PT; Lin YY
    Int J Nanomedicine; 2017; 12():6273-6287. PubMed ID: 28894366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
    Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
    Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
    Mohammadi M; Ramezani M; Abnous K; Alibolandi M
    Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tumor microenvironments on targeted delivery of glycol chitosan nanoparticles.
    Yhee JY; Jeon S; Yoon HY; Shim MK; Ko H; Min J; Na JH; Chang H; Han H; Kim JH; Suh M; Lee H; Park JH; Kim K; Kwon IC
    J Control Release; 2017 Dec; 267():223-231. PubMed ID: 28917532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysaccharide-based nanoparticles for theranostic nanomedicine.
    Swierczewska M; Han HS; Kim K; Park JH; Lee S
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):70-84. PubMed ID: 26639578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Plasmonic Gold Nanoparticle for Drug Delivery System.
    Lee JH; Choi JW
    Curr Drug Targets; 2018 Feb; 19(3):271-278. PubMed ID: 28460609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo targeted delivery of nanoparticles for theranosis.
    Koo H; Huh MS; Sun IC; Yuk SH; Choi K; Kim K; Kwon IC
    Acc Chem Res; 2011 Oct; 44(10):1018-28. PubMed ID: 21851104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery.
    Xie Z; Su Y; Kim GB; Selvi E; Ma C; Aragon-Sanabria V; Hsieh JT; Dong C; Yang J
    Small; 2017 Mar; 13(10):. PubMed ID: 28026115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the synthesis and application of nanoparticles for drug delivery.
    Park W; Na K
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(4):494-508. PubMed ID: 25583540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.
    Overchuk M; Zheng G
    Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic applications of nanoparticles in cancer.
    Ahmed N; Fessi H; Elaissari A
    Drug Discov Today; 2012 Sep; 17(17-18):928-34. PubMed ID: 22484464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
    Lim EK; Chung BH; Chung SJ
    Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer nanotheranostics: Strategies, promises and impediments.
    Roy Chowdhury M; Schumann C; Bhakta-Guha D; Guha G
    Biomed Pharmacother; 2016 Dec; 84():291-304. PubMed ID: 27665475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic Upconversion Nanobeacons for Tumor mRNA Ratiometric Fluorescence Detection and Imaging-Monitored Drug Delivery.
    Ding Q; Zhan Q; Zhou X; Zhang T; Xing D
    Small; 2016 Nov; 12(43):5944-5953. PubMed ID: 27647762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
    Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.